AC Immune (ACIU) Revenue (2014 - 2026)

AC Immune's (ACIU) quarterly Revenue came in at $1.4 million in Q1 2026, up 29.77% year-on-year from $1.1 million in Q1 2025, and up 237.9% on a QoQ basis from $422895.4 in Q4 2025.

AC Immune (ACIU) Revenue (2014 - 2026) Analysis & Trends

AC Immune (ACIU) has 11 years of Revenue data on file, last reported at $1.4 million in Q1 2026.

  • On a quarterly basis, Revenue rose 29.77% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 85.87% decrease from a year earlier, with the FY2025 full-year figure at $4.3 million, down 86.18% from the prior year.
  • Revenue for Q1 2026 stood at $1.4 million, up from $422895.4 in the prior quarter.
  • Over the last five years, Revenue for ACIU reached as high as $29.4 million in Q3 2024 and fell as low as $422895.4 in Q4 2025.
  • Historically, Revenue has averaged $4.6 million across 4 years, with a median of $1.3 million in 2024.
  • On a YoY basis, Revenue climbed as much as 107.65% in 2025 and fell as far as 96.01% in 2025.
  • Year by year, Revenue stood at $4.0 million in 2022, then plunged by 67.86% to $1.3 million in 2024, then plunged by 67.42% to $422895.4 in 2025, then jumped by 237.9% to $1.4 million in 2026.
  • Per Business Quant data, the three most recent Revenue figures were $1.4 million in Q1 2026, $422895.4 in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 AC Immune 222.66 Mn 222.66 Mn - 1.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.43 Mn
Dec 31, 2025 422,895.39
Sep 30, 2025 1.17 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 1.30 Mn
Sep 30, 2024 29.41 Mn
Jun 30, 2024 759,680.13
Sep 30, 2022 4.04 Mn
Dec 31, 2020 1.04 Mn
Sep 30, 2020 1.22 Mn
Jun 30, 2020 1.12 Mn
Mar 31, 2020 12.70 Mn
Dec 31, 2019 868,929.92
Sep 30, 2019 2.23 Mn
Jun 30, 2019 1.51 Mn
Mar 31, 2019 75.35 Mn
Dec 31, 2018 1.13 Mn
Sep 30, 2018 2.34 Mn
Jun 30, 2018 2.06 Mn